View in EDS HTML Full Text PDF Full Text

Faricimab (Vabysmo®, Roche Products Ltd) for visual impairment due to macular oedema secondary to retinal vein occlusion: An educational supplement.

Saved in:

Bibliographic Details
Title:	Faricimab (Vabysmo®, Roche Products Ltd) for visual impairment due to macular oedema secondary to retinal vein occlusion: An educational supplement.
Authors:	Sivaprasad, Sobha¹, Downey, Louise², Nicholson, Luke¹, Mushtaq, Bushra³, Wilkinson, Elizabeth⁴, Reynolds, Rhianon⁵, Dinah, Christiana⁶, Varma, Deepali⁷, Cackett, Peter⁸, Williams, Michael⁹, Pohler, Richard¹⁰
Source:	Ophthalmology Times Europe. Mar/Apr2026, Vol. 22 Issue 2, p1-15. 15p.
Database:	Academic Search Ultimate
Full text is not displayed to guests. Login for full access.

Description
ISSN:	17533066